PrimeRFP SCOUT · Federal Contract Recompete Brief

W912DR23P0006Modification to exercise OPTION YEAR 1 — Idexx Laboratories Inc

Idexx Laboratories Inc holds $1.1M across 210 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 3 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. PoP ended Feb 5, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W2sd Endist Baltimore
Awarding office
Idexx Laboratories Inc
Recipient
Feb 5, 2026
PoP end
$262K
Obligated
$340K
Potential
325180
NAICS
R799
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract numberW912DR23P0006
Also listed asW912DR-23-P-0006
AgencyW2sd Endist Baltimore
Awarding officeW2sd Endist Baltimore
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentIdexx Laboratories Inc
CAGE0USV5
UEIUJTGU4PX3DN8
NAICS325180

No full NAICS 325180 intel page yet. Browse NAICS intelligence

PSCR799
Place of performanceWASHINGTON DC
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
Related solicitationW912DR22Q0077
PoP startFeb 6, 2023
PoP end (current)Feb 5, 2026
PoP end (w/ options)Feb 5, 2028
Obligated$262K
Current value$340K
Potential value$340K

MODIFICATION TO EXERCISE OPTION YEAR 1 - 6 FEBRUARY 2024 TO 5 FEBRUARY 2025 is a federal Unrestricted award for W2sd Endist Baltimore held by Idexx Laboratories Inc. Estimated value $340K ($262K obligated). Current period of performance ends Feb 5, 2026 (potential Feb 5, 2028). Last award drew 1 bidder. Place of performance: WASHINGTON DC. Related solicitation W912DR22Q0077.

MODIFICATION TO EXERCISE OPTION YEAR 1 - 6 FEBRUARY 2024 TO 5 FEBRUARY 2025

Recompete timing

Public
● Past PoP end (234 days ago)

Current PoP ended Feb 5, 2026 (234 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on W912DR23P0006? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Idexx Laboratories Inc — $1.1M obligated across 210 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($1.1M) · all agencies · Top 4 shown (96%); remaining ~4% is other agencies.
Department of Defense (DOD)$888K · 81%Department of Agriculture (USDA)$111K · 10%Department of Homeland Security (DHS)$31K · 3%
Smithsonian Institution (SI)$30K · 3%
Open full company profile →

Related awards

Same incumbent
W911QX24P0253
BLOOD SMEAR SAMPLE ANALYSIS SERVICES
$139K
Sep 30, 2026
N0010426PBH04
REAGENT POWDER
$103K
Jan 13, 2027
1232SA25P0452
IDEXX SWINE INFLUENZA VIRUS AB TESTS.
$111K
Sep 21, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W912DR23P0006?

W912DR23P0006 (Modification to exercise OPTION YEAR 1) is a W2sd Endist Baltimore award with a potential value of $340K, currently held by Idexx Laboratories Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W912DR-23-P-0006?

W912DR-23-P-0006 is the dashed form of PIID W912DR23P0006 (Modification to exercise OPTION YEAR 1), held by Idexx Laboratories Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W912DR23P0006?

W2sd Endist Baltimore awarded W912DR23P0006 to Idexx Laboratories Inc (potential $340K).

Who is the incumbent on W912DR23P0006?

Idexx Laboratories Inc is the incumbent with $1.1M across 210 related awards in SCOUT’s public footprint. The current period of performance ends Feb 5, 2026.

When does Idexx Laboratories Inc’s W912DR23P0006 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 5, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on W912DR23P0006? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W912DR23P0006